Comparative pharmacokinetics of two crystalline forms of famotidine in dogs
โ Scribed by M. Kozma; M. Vajda; L. Vereczkey
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 284 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0731-7085
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A new sustained release dosage form of valproic acid (VPA) was developed. The new sustained release dosage form was administered (twice, with and without food) to five dogs in comparison to a standard tablet (Depakine, Labaz) and an i.v. preparation of the drug. Drug level monitoring in the plasma w
Pharmacokinetic studies in dogs were performed with a series of three 2,2-dimethylaziridine antineoplastic agents. These alkylating agents were relatively unstable in all aqueous media, with half-lives of 9-15 min in whole canine blood. This finding indicates that the aziridine compounds are capable
The pharmacokinetic profile of sulfisoxazole was studied and compared in dogs, swine, and humans. The trial was conducted over a 72-hr period after intravenous administration and a 96-hr period after oral administration in dogs and swine. In humans, the trial was conducted over an 8-hr period after